RPRX icon

Royalty Pharma

265 hedge funds and large institutions have $10.7B invested in Royalty Pharma in 2021 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 106 increasing their positions, 66 reducing their positions, and 27 closing their positions.

Holders
265
Holders Change
+34
Holders Change %
+14.72%
% of All Funds
4.09%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
63
Increased
106
Reduced
66
Closed
27
Calls
$49.1M
Puts
$11.2M
Net Calls
+$37.9M
Net Calls Change
+$9.57M
Name Market Value Shares Shares
Change
Shares
Change %
DCM
276
Dupont Capital Management
Delaware
-11,487 Closed
Voloridge Investment Management
277
Voloridge Investment Management
Florida
-11,195 Closed
VF
278
Virtu Financial
New York
-9,833 Closed
FRM
279
Fox Run Management
Connecticut
-8,659 Closed
PCM
280
Prelude Capital Management
New York
-6,560 Closed
Vontobel Holding
281
Vontobel Holding
Switzerland
-6,105 Closed
NICM
282
Neo Ivy Capital Management
New York
-1,102 Closed
Northwestern Mutual Wealth Management
283
Northwestern Mutual Wealth Management
Wisconsin
-750 Closed
AIM
284
Achmea Investment Management
Netherlands
-491 Closed
CG
285
Cutler Group
California
-440 Closed
Loomis, Sayles & Company
286
Loomis, Sayles & Company
Massachusetts
-228 Closed
EWA
287
Evolution Wealth Advisors
Florida
-154 Closed
JCM
288
Jacobi Capital Management
Pennsylvania
-102 Closed
EI
289
Ellevest Inc
New York
-75 Closed
Parallax Volatility Advisers
290
Parallax Volatility Advisers
California
Group One Trading
291
Group One Trading
Illinois
HT
292
HAP Trading
New York
CFGS
293
Concourse Financial Group Securities
Alabama
SA
294
SpiderRock Advisors
Delaware
Twin Tree Management
295
Twin Tree Management
Texas
CAL
296
Capital Advisors Ltd
Ohio
$0 6 +6 New
FF
297
FourThought Financial
Florida
$0 12 +12 New
SCA
298
Snowden Capital Advisors
New York
$0 20 +20 New